238MO PROMENADE: PembROlizuMab for early triple negative ER-low breast caNcer, reAl worlD frEnch cohort. - Cherifi, F.; Cabel, L.; Bousrih, C.; Volant, E.; Dalenc, F.; Mery, B.; Kuentz, M. Auvray; Alexandre, M.; Benistant, L.; Leheurteur, M.; Bailleux, C.; Debled, M.; et al. (Annals of Oncology, 2024)